I 
109TH CONGRESS 
1ST SESSION H. R. 2541 
To amend the Public Health Service Act to provide for the expansion, inten-
sification, and coordination of the activities of the National Institutes 
of Health regarding qualifying adult stem cell research, and for other 
purposes. 
IN THE HOUSE OF REPRESENTATIVES 
MAY 23, 2005 
Mr. KING of New York (for himself, Mr. SMITH of New Jersey, Mr. NOR-
WOOD, Mr. ISRAEL, and Mr. BISHOP of New York) introduced the fol-
lowing bill; which was referred to the Committee on Energy and Com-
merce 
A BILL 
To amend the Public Health Service Act to provide for 
the expansion, intensification, and coordination of the 
activities of the National Institutes of Health regarding 
qualifying adult stem cell research, and for other pur-
poses. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Joe Testaverde Adult 
Stem Cell Research Act of 2005’’.
SEC. 2. EXPANSION, INTENSIFICATION, AND COORDINA-
TION OF ACTIVITIES OF NATIONAL INSTI-
TUTES OF HEALTH REGARDING QUALIFYING 
ADULT STEM CELL RESEARCH. 
Part B of title IV of the Public Health Service Act 
(42 U.S.C. 284 et seq.) is amended by adding at the end 
the following: 
‘‘SEC. 409J. QUALIFYING ADULT STEM CELL RESEARCH. 
‘‘(a) IN GENERAL.— 
‘‘(1) EXPANSION OF ACTIVITIES.—The Director 
of NIH shall expand, intensify, and coordinate the 
activities of the National Institutes of Health re-
garding qualifying adult stem cell research. 
‘‘(2) COLLABORATION AMONG AGENCIES.—The 
Director shall carry out this section in collaboration 
with any other agencies that the Director determines 
appropriate. 
‘‘(b) CENTERS OF EXCELLENCE.— 
‘‘(1) IN GENERAL.—In carrying out subsection 
(a)(1), the Director shall make awards of grants and 
contracts to public or nonprofit private entities to 
pay all or part of the cost of planning, establishing, 
improving, and providing basic operating support for 
centers of excellence regarding qualifying adult stem 
cell research.
‘‘(2) RESEARCH.—Each center shall conduct 
basic and clinical research regarding qualifying adult 
stem cells. Such research should include investiga-
tions into the cause, diagnosis, early detection, pre-
vention, control, and treatment of disease. 
‘‘(3) SERVICES FOR PATIENTS.— 
‘‘(A) IN GENERAL.—A center may expend 
amounts provided under paragraph (1) to carry 
out a program to make individuals aware of op-
portunities to participate as subjects in research 
conducted by the centers. 
‘‘(B) REFERRALS AND COSTS.—A program 
under subparagraph (A) may, in accordance 
with such criteria as the Director may establish, 
provide to the subjects described in such sub-
paragraph, referrals for health and other serv-
ices, and such patient care costs as are required 
for research. 
‘‘(C) AVAILABILITY AND ACCESS.—The ex-
tent to which a center can demonstrate avail-
ability and access to clinical services shall be 
considered by the Director in decisions about 
awarding grants to applicants which meet the 
scientific criteria for funding under this section.
‘‘(4) COORDINATION OF CENTERS; REPORTS.— 
The Director shall, as appropriate, provide for the 
coordination of information among centers and en-
sure regular communication between such centers, 
and may require the periodic preparation of reports 
on the activities of the centers and the submission 
of the reports to the Director. 
‘‘(5) ORGANIZATION OF CENTERS.—Each cen-
ter shall use the facilities of a single institution, or 
be formed from a consortium of cooperating institu-
tions, meeting such requirements as may be pre-
scribed by the Director. 
‘‘(6) NUMBER OF CENTERS; DURATION OF SUP-
PORT.— 
‘‘(A) IN
GENERAL.—The Director shall 
provide for the establishment of not less than 
five centers under paragraph (1). 
‘‘(B) DURATION.—Support for a center 
may be provided under this section for a period 
of not to exceed 5 years. Such period may be 
extended for one or more additional periods not 
exceeding 5 years if the operations of such cen-
ter have been reviewed by an appropriate tech-
nical and scientific peer review group estab-
lished by the Director and if such group has
recommended to the Director that such period 
should be extended. 
‘‘(c) FACILITATION OF RESEARCH.—In carrying out 
subsection (a)(1), the Director shall provide for a program 
under which samples of tissues and genetic materials that 
are of use in qualifying adult stem cell research are do-
nated, collected, preserved, and made available for such 
research. The program shall be carried out in accordance 
with accepted scientific and medical standards for the do-
nation, collection, and preservation of such samples. 
‘‘(d) PUBLIC INPUT.—In carrying out subsection 
(a)(1), the Director shall provide for means through which 
the public can obtain information on the existing and 
planned programs and activities of the National Institutes 
of Health regarding qualifying adult stem cell research 
and through which the Director can receive comments 
from the public regarding such programs and activities. 
‘‘(e) DEFINITIONS.—In this section: 
‘‘(1) The term ‘center’ means a center of excel-
lence under subsection (b)(1). 
‘‘(2) The term ‘Director’ means the Director of 
NIH. 
‘‘(3) The term ‘qualifying adult stem cell’ 
means a human stem cell obtained from a human 
placenta, umbilical cord blood, an organ or tissue of
a living or deceased human being who has been 
born, or an organ or tissue of unborn human off-
spring who died of natural causes (such as sponta-
neous abortion). 
‘‘(f) AUTHORIZATION
OF
APPROPRIATIONS.—To 
carry out this section, there are authorized to be appro-
priated such sums as may be necessary for fiscal year 
2006 and each subsequent fiscal year. Such authorization 
of appropriations is in addition to any other authorization 
of appropriations that is available for activities of the Na-
tional Institutes of Health regarding qualifying adult stem 
cell research.’’. 
Æ